Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast
October 22, 2014 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals Announces Top-Line Part A Results From Phase 1/2 Trial of Necuparanib in Patients With Pancreatic Cancer
October 09, 2014 16:15 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, announced...
Momenta Pharmaceuticals to Host 2014 R&D Day
October 02, 2014 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals to Webcast Presentation at BioCentury's NewsMakers in the Biotech Industry Conference
September 17, 2014 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Exercises Option to Acquire Novel Antibodies From AnaptysBio
September 08, 2014 08:30 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Abbreviated New Drug Application for Three-Times-a-Week Generic Copaxone Accepted for Review by FDA
August 28, 2014 09:25 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals (Nasdaq:MNTA) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New...
Momenta Pharmaceuticals Reports Second Quarter 2014 Financial Results
July 31, 2014 08:00 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 31, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the second quarter ended June 30, 2014.
For the second...
Momenta Pharmaceuticals to Webcast Presentation at the Canaccord Genuity Growth Conference
July 30, 2014 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 30, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
Momenta Pharmaceuticals Announces Date of Second Quarter 2014 Financial Results Conference Call and Webcast
July 15, 2014 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., July 15, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
Momenta Pharmaceuticals to Webcast Presentation at the Wells Fargo Healthcare Conference
June 09, 2014 16:05 ET
|
Momenta Pharmaceuticals
CAMBRIDGE, Mass., June 9, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...